New ophthalmological formulations – multi-component nanoliposomal drops and ointments enriched with non-steroidal and anti-inflammatory and antibiotic components (Q78561)
Jump to navigation
Jump to search
Project Q78561 in Poland
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | New ophthalmological formulations – multi-component nanoliposomal drops and ointments enriched with non-steroidal and anti-inflammatory and antibiotic components |
Project Q78561 in Poland |
Statements
10,846,285.41 zloty
0 references
16,098,930.04 zloty
0 references
67.37 percent
0 references
1 June 2019
0 references
30 September 2023
0 references
SUPROBION SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA KOMANDYTOWA
0 references
Celem projektu jest opracowanie nowych wyrobów - wieloskładnikowych nanoliposomalnych kropli oraz maści wzbogaconych o niesteroidowe składniki o działaniu przeciwzapalnym i antybiotycznym charakterystycznych tym, że: - Zastosowanie fosfolipidów w formie nanoliposomów w celu uzupełnienia warstwy tłuszczowej płynu łzowego. Fosfolipidy, dzięki specyficznej budowie, pozwalają na uzyskanie monowarstwy lipidowej na powierzchni filmu łzowego. Na rynku pojawiły się krople do oczu w formie emulsji, zawierające w składzie najczęściej oleje mineralne, oleje roślinne lub średniołańcuchowe glicerydy, oraz spraye z liposomami, do stosowania na zamknięte powieki, po otwarciu których tłuszcze rozprowadzane są na powierzchni oka jako forma suplementacji warstwy tłuszczowej płynu łzowego - Zastosowanie białka lipokaliny umożliwi równomierne rozprowadzenie filmu łzowego na powierzchni oka i zapewni jego stabilność, a także opóźni odparowywanie, co będzie skutkować dłuższą retencją kropli na powierzchni oka i ograniczy konieczność częstego powtarzania aplikacji - Dzięki zastosowaniu chitozanu w połączeniu z kwasem hialuronowym krople będą mieć większą lepkość, dzięki czemu będą dłużej pozostawać na powierzchni oka i możliwe będzie ograniczenie częstości powtarzania aplikacji w porównaniu do produktów konkurencyjnych - Wzbogacenie opracowywanych maści o niesteroidowe składniki o działaniu przeciwzapalnym i antybiotycznym. Zgodnie z art. 25 rozporządzenia KE nr 651/2014 z dnia 17 czerwca 2014 r. uznające niektóre rodzaje pomocy za zgodne z rynkiem wewnętrznym w stosowaniu art. 107 i 108 Traktatu (Dz. Urz. UE L 187/1 z 26.06.2014) (Polish)
0 references
The aim of the project is to develop new products – multi-component nanoliposomal drops and ointments enriched with non-steroidal components with anti-inflammatory and antibiotic action characteristic in that: — Use of phospholipids in the form of nanolyposoms to supplement the fat layer of lacrimal fluid. Phospholipids, thanks to their specific design, allow to obtain lipid monolayer on the surface of the tear film. On the market have appeared eye drops in the form of emulsion, containing mostly mineral oils, vegetable oils or medium chain glycerides, and sprays with liposomes, to be used on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid will often be applied – the use of the lipocaline protein will allow even distribution of the tear film from the surface of the eye, and ensure its stability. Pursuant to Article 25 of Regulation (EC) No 651/2014 of 17 June 2014 declaring certain types of aid compatible with the internal market in the application of Articles 107 and 108 of the Treaty (OJ L. I'm sorry. EU L 187/1 of 26.06.2014) (English)
14 October 2020
0.5165932398269575
0 references
L’objectif du projet est de développer de nouveaux produits — gouttes et onguents nanoliposomal multicomposants enrichis d’ingrédients non stéroïdiens avec des effets anti-inflammatoires et antibiotiques caractéristiques: — L’utilisation de phospholipides sous forme de nanoliposomes pour compléter la couche de graisse du liquide lacrymal. Les phospholipides, grâce à leur structure spécifique, permettent d’obtenir une monocouche lipidique à la surface du film lacrymal. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will Conformément à l’article 25 du règlement (CE) no 651/2014 du 17 juin 2014 déclarant certaines catégories d’aides compatibles avec le marché intérieur en application des articles 107 et 108 du traité C’est tout. UE L 187/1 du 26.6.2014) (French)
30 November 2021
0 references
Ziel des Projekts ist es, neue Produkte zu entwickeln – Mehrkomponenten-Nanoliposomentropfen und Salben, angereichert mit nichtsteroidalen Inhaltsstoffen mit entzündungshemmenden und antibiotischen Effekten, die charakteristisch sind: — Die Verwendung von Phospholipiden in Form von Nanoliposomen zur Ergänzung der Fettschicht der Tränenflüssigkeit. Phospholipide ermöglichen dank ihrer spezifischen Struktur eine Lipid-Monoschicht auf der Oberfläche des Tränenfilms. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will Gemäß Artikel 25 der Verordnung (EG) Nr. 651/2014 vom 17. Juni 2014 zur Feststellung der Vereinbarkeit bestimmter Gruppen von Beihilfen mit dem Binnenmarkt in Anwendung der Artikel 107 und 108 AEUV Das war’s. EU L 187/1 vom 26.6.2014) (German)
7 December 2021
0 references
Het doel van het project is om nieuwe producten te ontwikkelen — multicomponent nanoliposomale druppels en zalven verrijkt met niet-steroïde ingrediënten met anti-inflammatoire en antibiotica effecten karakteristiek dat: — Het gebruik van fosfolipiden in de vorm van nanoliposomen om de vetlaag van de traanvloeistof aan te vullen. Fosfolipiden, dankzij hun specifieke structuur, maken het mogelijk om lipide monolaag op het oppervlak van de traanfilm te verkrijgen. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will Overeenkomstig artikel 25 van Verordening (EG) nr. 651/2014 van 17 juni 2014 waarbij bepaalde categorieën steun op grond van de artikelen 107 en 108 van het Verdrag met de interne markt verenigbaar worden verklaard Dat is het. EU L 187/1 van 26.6.2014) (Dutch)
16 December 2021
0 references
L'obiettivo del progetto è quello di sviluppare nuovi prodotti — gocce e unguenti nanoliposomi multicomponenti arricchiti con ingredienti non steroidei con effetti antinfiammatori e antibiotici caratteristici che: — L'uso di fosfolipidi sotto forma di nanoliposomi per integrare lo strato grasso del liquido lacrimale. I fosfolipidi, grazie alla loro specifica struttura, permettono di ottenere monostrato lipidico sulla superficie del film lacrimale. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will A norma dell'articolo 25 del regolamento (CE) n. 651/2014, del 17 giugno 2014, che dichiara talune categorie di aiuti compatibili con il mercato interno in applicazione degli articoli 107 e 108 del trattato È tutto qui. UE L 187/1 del 26.6.2014) (Italian)
15 January 2022
0 references
El objetivo del proyecto es desarrollar nuevos productos: gotas nanoliposomales multicomponentes y pomadas enriquecidas con ingredientes no esteroideos con efectos antiinflamatorios y antibióticos característicos que: — El uso de fosfolípidos en forma de nanoliposomas para complementar la capa grasa del líquido lagrimal. Los fosfolípidos, gracias a su estructura específica, permiten obtener monocapa lipídica en la superficie de la película lagrimal. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will De conformidad con el artículo 25 del Reglamento (CE) n.º 651/2014, de 17 de junio de 2014, por el que se declaran determinadas categorías de ayudas compatibles con el mercado interior en aplicación de los artículos 107 y 108 del Tratado Eso es todo. UE L 187/1 de 26.6.2014) (Spanish)
19 January 2022
0 references
Projekti eesmärk on töötada välja uued tooted – multikomponentsed nanoliposomaalsed tilgad ja salvid, mis on rikastatud mittesteroidsete koostisosadega, millel on põletikuvastane ja antibiootikumne toime, mis: – Fosfolipiidide kasutamine nanoliposoomide kujul, et täiendada pisarvedeliku rasvakihti. Tänu oma spetsiifilisele struktuurile võimaldavad fosfolipiidid saada lipiidide monokihti pisarkile pinnal. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will Vastavalt 17. juuni 2014. aasta määruse (EL) nr 651/2014 (ELi toimimise lepingu artiklite 107 ja 108 kohaldamise kohta, millega teatavat liiki abi tunnistatakse siseturuga kokkusobivaks) artiklile 25 See on kõik. EL L 187/1, 26.6.2014) (Estonian)
13 August 2022
0 references
Projekto tikslas – sukurti naujus produktus – daugiakomponentus nanoliposominius lašus ir tepalus, praturtintus nesteroidiniais ingredientais, pasižyminčiais priešuždegiminiu ir antibiotiku: Fosfolipidų naudojimas nanoliposomų pavidalu, siekiant papildyti ašarinio skysčio riebalų sluoksnį. Fosfolipidai, dėl jų specifinės struktūros, leidžia gauti lipidų monosluoksnį ant ašarinės plėvelės paviršiaus. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will Pagal 2014 m. birželio 17 d. Reglamento (EB) Nr. 651/2014, kuriuo tam tikrų kategorijų pagalba skelbiama suderinama su vidaus rinka taikant Sutarties 107 ir 108 straipsnius, 25 straipsnį Štai ir viskas. EU L 187/1, 2014 6 26) (Lithuanian)
13 August 2022
0 references
Cilj projekta je razviti nove proizvode – multikomponentne nanoliposomalne kapi i masti obogaćene nesteroidnim sastojcima s protuupalnim i antibiotskim učincima karakterističnim za: — Korištenje fosfolipida u obliku nanoliposoma za nadopunu masnog sloja suza tekućine. Fosfolipidi, zahvaljujući svojoj specifičnoj strukturi, omogućuju dobivanje lipidnog monosloja na površini suznog filma. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will U skladu s člankom 25. Uredbe (EZ) br. 651/2014 od 17. lipnja 2014. o ocjenjivanju određenih kategorija potpora spojivima s unutarnjim tržištem u primjeni članaka 107. i 108. Ugovora To je sve. EU L 187/1 od 26.6.2014.) (Croatian)
13 August 2022
0 references
Στόχος του έργου είναι η ανάπτυξη νέων προϊόντων — πολυσυστατικών νανολιποσωματικών σταγόνων και αλοιφών εμπλουτισμένων με μη στεροειδή συστατικά με αντιφλεγμονώδη και αντιβιοτικά χαρακτηριστικά που: — Η χρήση φωσφολιπιδίων με τη μορφή νανολιποσωμάτων για τη συμπλήρωση του στρώματος λίπους του υγρού δακρύων. Τα φωσφολιπίδια, χάρη στη συγκεκριμένη δομή τους, επιτρέπουν την απόκτηση μονοστρώματος λιπιδίων στην επιφάνεια του δακρυϊκού φιλμ. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will Σύμφωνα με το άρθρο 25 του κανονισμού (ΕΚ) αριθ. 651/2014, της 17ης Ιουνίου 2014, για την κήρυξη ορισμένων κατηγοριών ενισχύσεων ως συμβατών με την εσωτερική αγορά κατ’ εφαρμογή των άρθρων 107 και 108 της Συνθήκης Αυτό είναι όλο. ΕΕ L 187/1 της 26.6.2014) (Greek)
13 August 2022
0 references
Cieľom projektu je vyvinúť nové produkty – viaczložkové nanolipozomálne kvapky a masti obohatené o nesteroidné zložky s protizápalovými a antibiotickými účinkami, ktoré: Použitie fosfolipidov vo forme nanolipozómov na doplnenie tukovej vrstvy slznej tekutiny. Fosfolipidy, vďaka svojej špecifickej štruktúre, umožňujú získať lipidovú monovrstvu na povrchu slzného filmu. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will V súlade s článkom 25 nariadenia (ES) č. 651/2014 zo 17. júna 2014 o vyhlásení určitých kategórií pomoci za zlučiteľné s vnútorným trhom podľa článkov 107 a 108 zmluvy To je všetko. EÚ L 187/1 z 26.6.2014) (Slovak)
13 August 2022
0 references
Hankkeen tavoitteena on kehittää uusia tuotteita – monikomponenttisia nanoliposomaalisia pisaroita ja voiteita, joissa on ei-steroidisia ainesosia, joilla on anti-inflammatorisia ja antibioottisia vaikutuksia, jotka ovat ominaisia: — Fosfolipidien käyttö nanoliposomien muodossa kyynelnesteen rasvakerroksen täydentämiseksi. Fosfolipidit voivat erityisen rakenteensa ansiosta saada lipidimonokerroksen kyynelkalvon pinnalle. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will Tiettyjen tukimuotojen toteamisesta sisämarkkinoille soveltuviksi perussopimuksen 107 ja 108 artiklan mukaisesti 17 päivänä kesäkuuta 2014 annetun asetuksen (EY) N:o 651/2014 25 artiklan mukaisesti Se on siinä. EU L 187/1, 26.6.2014) (Finnish)
13 August 2022
0 references
A projekt célja új termékek kifejlesztése – többkomponensű nanoliposzómális cseppek és kenőcsök, amelyek nem szteroid összetevőkkel dúsítottak gyulladáscsökkentő és antibiotikum-hatásokkal, amelyek jellemzőek: – A foszfolipidek használata nanoliposzómák formájában a könnyfolyadék zsírrétegének kiegészítésére. A foszfolipidek sajátos szerkezetüknek köszönhetően lehetővé teszik a lipid monoréteg megszerzését a könnyfilm felületén. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will A Szerződés 107. és 108. cikke alkalmazásában bizonyos támogatási kategóriáknak a belső piaccal összeegyeztethetőnek nyilvánításáról szóló, 2014. június 17-i 651/2014/EK rendelet 25. cikkével összhangban Ez az. – Ez az. EU L 187/1, 2014.6.26.) (Hungarian)
13 August 2022
0 references
Cílem projektu je vyvinout nové produkty – vícesložkové nanolipozomální kapky a masti obohacené o nesteroidní složky s protizánětlivými a antibiotickými účinky charakteristickými: Použití fosfolipidů ve formě nanolipozmů k doplnění tukové vrstvy slzné tekutiny. Fosfolipidy díky své specifické struktuře umožňují získat lipidovou monovrstvu na povrchu slzného filmu. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will V souladu s článkem 25 nařízení (ES) č. 651/2014 ze dne 17. června 2014, kterým se v souladu s články 107 a 108 Smlouvy prohlašují určité kategorie podpory za slučitelné s vnitřním trhem To je všechno. EU L 187/1 ze dne 26.6.2014) (Czech)
13 August 2022
0 references
Projekta mērķis ir izstrādāt jaunus produktus — daudzkomponentu nanoliposomu pilienus un ziedes, kas bagātinātas ar nesteroīdām sastāvdaļām ar pretiekaisuma un antibiotiku iedarbību, kas raksturīgas: — Fosfolipīdu izmantošana nanoliposomu veidā, lai papildinātu asaru šķidruma tauku slāni. Fosfolipīdi, pateicoties to specifiskajai struktūrai, ļauj iegūt lipīdu monoslāni uz asaru plēves virsmas. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will Saskaņā ar 25. pantu 2014. gada 17. jūnija Regulā (EK) Nr. 651/2014, ar ko noteiktas atbalsta kategorijas atzīst par saderīgām ar iekšējo tirgu, piemērojot Līguma 107. un 108. pantu Tas ir viss. EU L 187/1, 26.6.2014.) (Latvian)
13 August 2022
0 references
Is é aidhm an tionscadail táirgí nua a fhorbairt — titeann agus ointíochtaí nanaliposomal ilchodacha atá saibhrithe le comhábhair neamhstéaróideacha a bhfuil éifeachtaí frith-athlastacha agus antaibheathacha acu: — Úsáid fosfailipidí i bhfoirm nanaliposomes chun ciseal saille an sreabhach cuimilte a fhorlíonadh. Ceadaíonn fosfailipidí, a bhuíochas dá struchtúr ar leith, monolayer lipid a fháil ar dhromchla an scannáin cuimilte. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will I gcomhréir le hAirteagal 25 de Rialachán (CE) Uimh. 651/2014 an 17 Meitheamh 2014 ina ndearbhaítear go bhfuil catagóirí áirithe cabhrach comhoiriúnach leis an margadh inmheánach i gcur i bhfeidhm Airteagail 107 agus 108 den Chonradh Sin é. AE L 187/1 an 26.6.2014) (Irish)
13 August 2022
0 references
Cilj projekta je razviti nove izdelke – večkomponentne nanoliposomske kapljice in mazila, obogatena z nesteroidnimi sestavinami z protivnetnimi in antibiotičnimi učinki, značilnimi za: — Uporaba fosfolipidov v obliki nanoliposomov za dopolnitev maščobne plasti solzne tekočine. Fosfolipidi zaradi svoje posebne strukture omogočajo pridobitev lipidnega monoplasta na površini solznega filma. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will V skladu s členom 25 Uredbe (ES) št. 651/2014 z dne 17. junija 2014 o razglasitvi nekaterih vrst pomoči za združljive z notranjim trgom pri uporabi členov 107 in 108 Pogodbe To je vse. EU L 187/1, 26.6.2014) (Slovenian)
13 August 2022
0 references
Целта на проекта е да се разработят нови продукти — многокомпонентни нанолипозомни капки и мехлеми, обогатени с нестероидни съставки с противовъзпалителни и антибиотични ефекти, характерни, че: — Използването на фосфолипиди под формата на нанолипозоми за допълване на мастния слой на сълзотворната течност. Фосфолипидите, благодарение на специфичната си структура, позволяват да се получи липиден монослой на повърхността на слъзния филм. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will В съответствие с член 25 от Регламент (ЕО) № 651/2014 от 17 юни 2014 г. за обявяване на някои категории помощи за съвместими с вътрешния пазар в приложение на членове 107 и 108 от Договора Това е всичко. EU L 187/1 от 26.6.2014 г.) (Bulgarian)
13 August 2022
0 references
L-għan tal-proġett huwa li jiżviluppa prodotti ġodda — qtar u ingwenti nanoliposomali multikomponenti arrikkiti b’ingredjenti mhux sterojdi b’effetti antiinfjammatorji u antibijotiċi li huma karatteristiċi li: — L-użu ta ‘fosfolipidi fil-forma ta’ nanoliposomi biex jissupplimentaw is-saff tax-xaħam tal-fluwidu tad-dmugħ. Il-fosfolipidi, bis-saħħa tal-istruttura speċifika tagħhom, jippermettu li jinkiseb saff wieħed lipidu fuq il-wiċċ tal-film tad-dmugħ. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will Skont l-Artikolu 25 tar-Regolament (KE) Nru 651/2014 tas-17 ta’ Ġunju 2014 li jiddikjara li ċerti kategoriji ta’ għajnuna huma kompatibbli mas-suq intern skont l-Artikoli 107 u 108 tat-Trattat Li huwa. UE L 187/1 tas-26.6.2014) (Maltese)
13 August 2022
0 references
O objetivo do projeto é desenvolver novos produtos – gotas e pomadas nanolipossomais multicomponentes enriquecidas com componentes não esteroides com ação anti-inflamatória e antibiótica característica, na medida em que: — Utilização de fosfolípidos sob a forma de nanopolímeros para complementar a camada de gordura do líquido lacrimal. Os fosfolípidos, graças ao seu design específico, permitem obter a monocamada lipídica na superfície da película lacrimal. No mercado, surgiram colírios sob a forma de emulsão, contendo principalmente óleos minerais, óleos vegetais ou glicéridos de cadeia média, e pulverizadores com lipossomas, para serem utilizados em pálpebras fechadas, após a abertura, cujas gorduras são distribuídas na superfície do olho como uma forma de suplementação da camada de gordura do fluido lacrimal será frequentemente aplicada — a utilização da proteína lipocalina permitirá uma distribuição uniforme da película lacrimal a partir da superfície do olho e garantirá a sua estabilidade. Nos termos do artigo 25.o do Regulamento (CE) n.o 651/2014, de 17 de junho de 2014, que declara certos tipos de auxílio compatíveis com o mercado interno, em aplicação dos artigos 107.o e 108.o do Tratado (JO L UE L 187/1 de 26.6.2014) (Portuguese)
13 August 2022
0 references
Formålet med projektet er at udvikle nye produkter — multikomponent nanoliposomale dråber og salver beriget med ikke-steroide ingredienser med antiinflammatoriske og antibiotiske virkninger karakteristisk, at: — Brug af fosfolipider i form af nanoliposomer til at supplere fedtlaget af tårevæsken. Fosfolipider, takket være deres specifikke struktur, gør det muligt at opnå lipidmonolag på overfladen af tårefilmen. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will I overensstemmelse med artikel 25 i forordning (EF) nr. 651/2014 af 17. juni 2014 om visse former for støttes forenelighed med det indre marked i henhold til traktatens artikel 107 og 108 Det er det. EU L 187/1 af 26.6.2014) (Danish)
13 August 2022
0 references
Scopul proiectului este de a dezvolta noi produse – picături nanolipozomiale multicomponente și unguente îmbogățite cu ingrediente nesteroidiene cu efecte antiinflamatorii și antibiotice caracteristice care: Utilizarea fosfolipidelor sub formă de nanolipozomi pentru a completa stratul de grăsime al lichidului lacrimal. Fosfolipidele, datorită structurii lor specifice, permit obținerea monostratului lipidic pe suprafața filmului lacrimal. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will În conformitate cu articolul 25 din Regulamentul (CE) nr. 651/2014 din 17 iunie 2014 de declarare a anumitor categorii de ajutoare compatibile cu piața internă în aplicarea articolelor 107 și 108 din tratat Asta e tot. UE L 187/1 din 26.6.2014) (Romanian)
13 August 2022
0 references
Syftet med projektet är att utveckla nya produkter – multikomponent nanoliposomala droppar och salvor berikade med icke-steroida ingredienser med antiinflammatoriska och antibiotiska effekter som: — Användning av fosfolipider i form av nanoliposomer för att komplettera fettskiktet i tårvätskan. Fosfolipider, tack vare sin specifika struktur, gör det möjligt att få lipidmonolager på ytan av tårfilmen. Eye drops appeared on the market in the form of emulsions, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of the fat layer of the tear fluid — the use of lipocalin protein will allow the uniform distribution of tear film on the surface of the eye and will ensure its stability, as well as delays evaporation, which will result in a longer retention of droplets on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to stay longer in combination with antibacterial ingredients, which will result in a longer antibacterial effect of eye drops on the surface of the eye and will reduce the need for frequent repetition of the application — thanks to the application will be able to stay longer in combination with the anti-bacterial ingredients, which will often have antibacterial acid in the form of emulsion, containing in the composition most often mineral oils, vegetable oils or medium-chain glycerides, and sprays with liposome liposomes, for use on closed eyelids, after opening which fats are distributed on the surface of the eye as a form of supplementation of fat layer of tear fluid — the use of lipocalin protein will allow for the uniform distribution of the tear film on the surface of the eye and will ensure its stability, as well as delaying evaporation, which will result in a longer antimicrobial retention of drops on the surface of the eye and will reduce the need for frequent repetition of the application, thanks to the use of the application, will be able to keep the anti-drugs in combination with the anti-bacterium, which will result in a longer anti-aging effect of eye drops, and will reduce the need for frequent repetition of the application — thanks to the use of chitosanthely, it will be possible to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the anti-drugs to the surface of the eye, which will often be able to reduce the antihydrugally to the surface of the eye, which will often be able to reduce the anti-drug to the surface of the eye, which will often be able to reduce the anti-slips to the surface of the eye, and will often be able to keep the anti-slip products in combination with the anti-bacterial components, which will often be able to with anti-biotic acid, and will reduce the need for frequent repetition of the application — thanks to the use of chitozantine, it will be possible to reduce the anti-drug to the surface of the eye, will often be able to reduce the anti-bacterium, which will I enlighet med artikel 25 i förordning (EG) nr 651/2014 av den 17 juni 2014 genom vilken vissa kategorier av stöd förklaras förenliga med den inre marknaden enligt artiklarna 107 och 108 i fördraget Det är allt. EU L 187/1 av den 26 juni 26.6.2014) (Swedish)
13 August 2022
0 references
WOJ.: DOLNOŚLĄSKIE, POW.: wrocławski
0 references
24 May 2023
0 references
Identifiers
POIR.01.01.01-00-1054/18
0 references